Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease.
about
Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob diseaseCSF biomarkers for mild cognitive impairment.Identification of oligomers at early stages of tau aggregation in Alzheimer's disease.Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's diseaseCerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease.CSF tau and β-amyloid as biomarkers for mild cognitive impairment.Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological diseaseCSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.Cerebrospinal fluid protein biomarkers for Alzheimer's disease.Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older womenCerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.Precision Medicine: Clarity for the Complexity of Dementia.Alzheimer's disease and mild cognitive impairmentCerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia.Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.Cerebrospinal fluid tau and Abeta42 concentrations in healthy subjects: delineation of reference intervals and their limitations.Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.To tap or not to tap: cerebrospinal fluid biomarkers of Alzheimer's disease.Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population.New laboratory markers in diagnosis of alzheimer dementia.
P2860
Q28366081-1AD87DA0-AA78-49F3-8268-FC27D8EB3363Q30953185-09155FD0-A7E4-40DC-90B9-3E3D4AAC3B74Q33713341-E41A3B98-162C-4268-886C-0AB8C7C45FCEQ33850134-E4164EA8-F3CA-4FF8-9063-AA80B98022F5Q35005803-DA9244F5-5FAC-4B4A-8103-DB2214285EF4Q35236838-4C638BC1-44BB-4C46-9499-7C1E91D02FB6Q35529102-687B21C3-CB68-45D5-815B-7E82D613035EQ35580179-881393A5-9F97-45BA-BC7E-5CABD01B3E8EQ36045282-20DB33D4-2F46-4FA0-AD74-06DA933C8066Q36227420-C10E6C49-322E-4D35-95D4-A34958D25A01Q36382217-F81BE06A-118C-47D8-BA98-0C0979F90E19Q36753680-A9B1CB20-E9EC-42B6-9D6C-4D24CC19934BQ36894385-9AC495A9-1399-4C8C-9D2C-F04834592D12Q36933691-6536061E-58D4-4857-A2BA-7444E04899CFQ37358672-BD2AD9E7-3DF3-4A95-8288-743156C22F95Q41046533-85DA05E6-E44E-4578-9790-C694902AD438Q42912092-D86A5E81-7EE9-46A8-AF21-1EFD069028BEQ47595482-A9225C2B-7F96-4A68-A5BD-17F6FA9F5B33Q47831557-65D3C87F-C227-442C-8EA4-C3827A6AAF06Q47831582-95E0367D-967C-4CD4-A9E6-E0329D9893A4Q51917846-FE598CB7-01EF-43E2-A060-4491BF9752FFQ51944474-65BD859F-D893-49D0-A238-965411D6D902Q51988901-70B95DCD-A7E2-4B59-BDCA-DF53ED129DC5Q52983052-A6E9A0B8-7933-4FA1-92C5-4654FEB08C20Q53245453-597C3448-6641-406A-9E6F-8C06AA4DAF95Q53253261-1152CDF0-E05C-4CD5-9C11-A45C0E431528Q53303172-14D572D0-DB1C-4C17-85BE-F8CA237972AB
P2860
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Assessment of CSF levels of ta ...... ents with Alzheimer's disease.
@en
Assessment of CSF levels of ta ...... ents with Alzheimer's disease.
@nl
type
label
Assessment of CSF levels of ta ...... ents with Alzheimer's disease.
@en
Assessment of CSF levels of ta ...... ents with Alzheimer's disease.
@nl
prefLabel
Assessment of CSF levels of ta ...... ents with Alzheimer's disease.
@en
Assessment of CSF levels of ta ...... ents with Alzheimer's disease.
@nl
P2093
P356
P1433
P1476
Assessment of CSF levels of ta ...... ents with Alzheimer's disease.
@en
P2093
P304
P356
10.1212/WNL.48.3.632
P407
P577
1997-03-01T00:00:00Z